Whole-transcriptome Analysis of Fully Viable Energy Efficient Glycolytic-null Cancer Cells Established by Double Genetic Knockout of Lactate Dehydrogenase A/B or Glucose-6-Phosphate Isomerase.

作者: ELIZABETH MAZZIO , RAMESH BADISA , NZINGA MACK , SHAMIR CASSIM , MASA ZDRALEVIC

DOI: 10.21873/CGP.20205

关键词:

摘要: Background/aim Nearly all mammalian tumors of diverse tissues are believed to be dependent on fermentative glycolysis, marked by elevated production lactic acid and expression glycolytic enzymes, most notably dehydrogenase (LDH). Therefore, there has been significant interest in developing chemotherapy drugs that selectively target various isoforms the LDH enzyme. However, considerable questions remain as consequences biological ablation or upstream targeting pathway. Materials methods In this study, we explore biochemical whole transcriptomic effects CRISPR-Cas9 gene knockout (KO) lactate dehydrogenases A B [LDHA/B double KO (DKO)] glucose-6-phosphate isomerase (GPI KO) human colon cancer cell line LS174T, using Affymetrix 2.1 ST arrays. Results The metabolic profiles corroborate relative wild type (WT), LDHA/B DKO produced no acid, minimal both KOs displayed higher mitochondrial respiration, use glucose with loss viability. These findings show a high energy efficiency measured ATP glycolysis-null cells. Next, analysis conducted 48,226 mRNA transcripts reflect 273 differentially expressed genes (DEGS) GPI clone set, 193 DEGS set 47 DEGs common clones. Glycolytic-null cells up-regulation typically associated nutrient deprivation / fasting possible fats for energy: thioredoxin interacting protein (TXNIP), 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2), PPARγ coactivator 1α (PGC-1α), acetyl-CoA acyltransferase (ACAA2). Other changes non-ergometric losses "stemness", WNT signaling pathway, chemo/radiation resistance, retinoic synthesis, drug detoxification, androgen/estrogen activation, extracellular matrix reprogramming genes. Conclusion demonstrate that: 1) "Warburg effect" is dispensable, 2) LDHAB not only inconsequential viability but fosters greater energy, 3) likely ineffective without plausible combination second target.

参考文章(131)
C.-M. Cruciat, C. Niehrs, Secreted and Transmembrane Wnt Inhibitors and Activators Cold Spring Harbor Perspectives in Biology. ,vol. 5, ,(2013) , 10.1101/CSHPERSPECT.A015081
Hassan Ashktorab, Mohammad Daremipouran, Joe Devaney, Sudhir Varma, Hamed Rahi, Edward Lee, Babak Shokrani, Russell Schwartz, Michael L. Nickerson, Hassan Brim, Identification of novel mutations by exome sequencing in African American colorectal cancer patients. Cancer. ,vol. 121, pp. 34- 42 ,(2015) , 10.1002/CNCR.28922
Punit Saraon, Daniela Cretu, Natasha Musrap, George S. Karagiannis, Ihor Batruch, Andrei P. Drabovich, Theodorus van der Kwast, Atsushi Mizokami, Colm Morrissey, Keith Jarvi, Eleftherios P. Diamandis, Quantitative Proteomics Reveals that Enzymes of the Ketogenic Pathway are Associated with Prostate Cancer Progression Molecular & Cellular Proteomics. ,vol. 12, pp. 1589- 1601 ,(2013) , 10.1074/MCP.M112.023887
Huiyun Liang, Walter F. Ward, PGC-1α: a key regulator of energy metabolism Advances in Physiology Education. ,vol. 30, pp. 145- 151 ,(2006) , 10.1152/ADVAN.00052.2006
Ivan Ischenko, Hendrik Seeliger, Moshe Schaffer, Karl-Walter Jauch, Christiane Bruns, Cancer Stem Cells: How can we Target them? Current Medicinal Chemistry. ,vol. 15, pp. 3171- 3184 ,(2008) , 10.2174/092986708786848541
Lucie Zemanova, Jakub Hofman, Eva Novotna, Kamil Musilek, Tereza Lundova, Jana Havrankova, Anna Hostalkova, Jakub Chlebek, Lucie Cahlikova, Vladimír Wsol, Flavones Inhibit the Activity of AKR1B10, a Promising Therapeutic Target for Cancer Treatment. Journal of Natural Products. ,vol. 78, pp. 2666- 2674 ,(2015) , 10.1021/ACS.JNATPROD.5B00616
Vera Rötzer, Eva Hartlieb, Julia Winkler, Elias Walter, Angela Schlipp, Miklós Sardy, Volker Spindler, Jens Waschke, Desmoglein 3-Dependent Signaling Regulates Keratinocyte Migration and Wound Healing. Journal of Investigative Dermatology. ,vol. 136, pp. 301- 310 ,(2016) , 10.1038/JID.2015.380
Shunsuke Sato, Takuya Genda, Takafumi Ichida, Ayato Murata, Hironori Tsuzura, Yutaka Narita, Yoshio Kanemitsu, Sachiko Ishikawa, Tetsu Kikuchi, Masashi Mori, Katsuharu Hirano, Katsuyori Iijima, Ryo Wada, Akihito Nagahara, Sumio Watanabe, Impact of aldo-keto reductase family 1 member B10 on the risk of hepatitis C virus-related hepatocellular carcinoma Journal of Gastroenterology and Hepatology. ,vol. 31, pp. 1315- 1322 ,(2016) , 10.1111/JGH.13295
Li Huang, Rongzhang He, Weihao Luo, Yuan-Shan Zhu, Jia Li, Tan Tan, Xi Zhang, Zheng Hu, Dixian Luo, Aldo-Keto Reductase Family 1 Member B10 Inhibitors: Potential Drugs for Cancer Treatment. Recent Patents on Anti-cancer Drug Discovery. ,vol. 11, pp. 184- 196 ,(2016) , 10.2174/1574892811888160304113346